Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000694095 | SCV000822522 | likely benign | Duchenne muscular dystrophy | 2024-11-15 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000766089 | SCV000897564 | uncertain significance | Becker muscular dystrophy; Duchenne muscular dystrophy; Dilated cardiomyopathy 3B | 2018-10-31 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV003144525 | SCV003829513 | uncertain significance | not provided | 2023-01-23 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004609491 | SCV005108236 | likely benign | Cardiovascular phenotype | 2024-03-21 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Natera, |
RCV001825355 | SCV002089656 | uncertain significance | Becker muscular dystrophy; Duchenne muscular dystrophy; Cardiomyopathy; Dystrophin deficiency | 2018-06-23 | no assertion criteria provided | clinical testing |